PATENT CLAIM ANALYSIS

Application Number: 15882689
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["435", "235100"]

Abstract:
Provided are a highly-safe recombinant vaccinia virus that is effective in preventing the onset of symptoms due to infection by novel influenza viruses, and a vaccine for the novel influenza viruses containing the recombinant vaccinia virus. This recombinant vaccinia virus is capable of expressing the hemagglutinin protein genes of the novel influenza virus. This novel influenza vaccine contains the recombinant vaccinia virus.

Claim (Index 6):
The influenza vaccine of  claim 1 , wherein the cDNA coding for hemagglutinin protein has a nucleic acid sequence consisting of SEQ ID NO: 14 and wherein the expression promoter is a hybrid promoter consisting of SEQ ID NO: 6.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.83333
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15289106', '12748265', '15107074', '13982524', '13003570']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6918542819736963
- 35 USC 102 Novelty (BERT): 0.5591646944408298
- Combined Prediction Score: 0.6785853232204097
- Mean Citation Score: 454.298122
- Max Citation Score: 472.80524
- Similarity Product: 351.59567951618675

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test